Texas probe targeted UnitedHealth Group. UnitedHealth Group stock fell 1.64 percent!??

Published on 10/08/2026 at 16:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Texas opened a probe on October 5, 2026 over alleged coverage practices. UnitedHealth Group stock costs EUR 330.10 on October 8, 2026 versus EUR 335.60.

Key points in brief

Texas Attorney General Ken Paxton opened an investigation into UnitedHealth Group on October 5, 2026.
Second-quarter 2026 revenue reached USD 112.0 billion, up 0.40 percent year over year, while the medical care ratio fell to 86.70 percent from 89.40 percent.
UnitedHealth Group stock was trading at EUR 330.10 at Lang & Schwarz on October 8, 2026 at 4:41 p.m. CEST, minus 1.64 percent versus the EUR 335.60 prior close.
UnitedHealth Group plans to release third-quarter 2026 results on October 13, 2026 before the market opens.

Fotorealistisches Krankenhaus-Außengebäude bei Sonnenuntergang mit Glasfassade und Fußgängern — UnitedHealth Group US91324P1021 zeigt modernes Krankenhaus im Sonnenuntergang mit Glasfassade und Besuchern, Illustration mit AI erstellt.

UnitedHealth Group (ISIN US91324P1021) was trading at EUR 330.10 at Lang & Schwarz on October 8, 2026 at 4:41 p.m. CEST, down 1.64 percent versus the prior close. The Texas Attorney General opened an investigation on October 5, 2026 into alleged deceptive practices involving coverage decisions, according to the Office of the Attorney General.

Three events shaped the setup

On September 15, 2026, UnitedHealth Group scheduled its third-quarter results for October 13, 2026 before the market opens, with an 8:00 a.m. ET conference call. On October 1, 2026, UnitedHealthcare introduced 2027 Medicare Advantage plans offering access to a plan for more than 94.00 percent of Medicare-eligible people, according to AFX News. On October 5, 2026, the Texas release cited one patient case and said civil investigative demands had been issued to gather evidence.

What does the probe mean for earnings?

The immediate financial backdrop is the second quarter of 2026. Revenue reached USD 112.0 billion versus USD 111.6 billion a year earlier, a 0.40 percent increase, while diluted earnings per share reached USD 6.04 versus USD 3.74, according to Financial Report Insights.

The medical care ratio was 86.70 percent in the second quarter of 2026, down from 89.40 percent in the second quarter of 2025. That 2.70 percentage-point improvement supported the earnings recovery, but the Texas investigation adds a legal and reputational risk ahead of the next report.

Results arrive October 13

The next key date is October 13, 2026, when UnitedHealth Group is scheduled to publish third-quarter 2026 results before the market opens. The company also said the call replay will remain available through October 27, 2026.

On the NYSE, UNH was last at USD 369.35 on October 8, 2026 at 10:51 a.m. ET. UnitedHealth Group had a market capitalization of USD 335.4 billion and a 52-week range of USD 255.97 to USD 461.62 as of October 8, 2026.

Price context: UnitedHealth Group was trading at EUR 330.10 at Lang & Schwarz on October 8, 2026 at 4:41 p.m. CEST, minus 1.64 percent versus the EUR 335.60 prior close at Lang & Schwarz on October 7, 2026. The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.